Moreover, withaferin-A treatment reduced the level of Bmi (B-cell-specific Moloney murine leukemia virus insertion region-1) protein, which has been implicated in the self-renewal of breast cancer stem cells [101], and reduced the ALDH1 activity in Bmi-overexpressing MCF-7 cells. This evidence concerns the gene ALDH1A1 and breast cancer.